CS252461B2 - Method of 2-guanidino-4-(2-subst.-amino-4-imidazolyl)thiazoles production - Google Patents

Method of 2-guanidino-4-(2-subst.-amino-4-imidazolyl)thiazoles production Download PDF

Info

Publication number
CS252461B2
CS252461B2 CS833184A CS318483A CS252461B2 CS 252461 B2 CS252461 B2 CS 252461B2 CS 833184 A CS833184 A CS 833184A CS 318483 A CS318483 A CS 318483A CS 252461 B2 CS252461 B2 CS 252461B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
iii
amino
compounds
nhr
Prior art date
Application number
CS833184A
Other languages
Czech (cs)
English (en)
Other versions
CS318483A2 (en
Inventor
John L Lamattina
Christopher A Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS318483A2 publication Critical patent/CS318483A2/cs
Publication of CS252461B2 publication Critical patent/CS252461B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Lubricants (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Cephalosporin Compounds (AREA)
CS833184A 1982-05-10 1983-05-05 Method of 2-guanidino-4-(2-subst.-amino-4-imidazolyl)thiazoles production CS252461B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/376,486 US4435396A (en) 1982-05-10 1982-05-10 Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor

Publications (2)

Publication Number Publication Date
CS318483A2 CS318483A2 (en) 1987-02-12
CS252461B2 true CS252461B2 (en) 1987-09-17

Family

ID=23485203

Family Applications (1)

Application Number Title Priority Date Filing Date
CS833184A CS252461B2 (en) 1982-05-10 1983-05-05 Method of 2-guanidino-4-(2-subst.-amino-4-imidazolyl)thiazoles production

Country Status (26)

Country Link
US (1) US4435396A (fr)
EP (1) EP0094191B1 (fr)
JP (1) JPS58206588A (fr)
KR (1) KR860000931B1 (fr)
AT (1) ATE33649T1 (fr)
AU (2) AU539244B2 (fr)
CA (1) CA1201120A (fr)
CS (1) CS252461B2 (fr)
DD (1) DD209828A5 (fr)
DE (1) DE3376322D1 (fr)
DK (1) DK163829B (fr)
EG (1) EG17029A (fr)
ES (1) ES8407045A1 (fr)
FI (1) FI78481C (fr)
GR (1) GR79279B (fr)
GT (1) GT198302123A (fr)
HU (2) HU196377B (fr)
IE (1) IE55229B1 (fr)
IL (1) IL68630A (fr)
NO (1) NO159932C (fr)
NZ (1) NZ204158A (fr)
PL (1) PL141199B1 (fr)
PT (1) PT76662B (fr)
SU (1) SU1195907A3 (fr)
YU (1) YU42857B (fr)
ZA (1) ZA833286B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
US4632993A (en) * 1984-10-11 1986-12-30 Pfizer Inc. Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide
WO1986003203A1 (fr) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Derives de thienylthiazole
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents
EP0259085B1 (fr) * 1986-08-29 1991-08-21 Pfizer Inc. Guanidino-2 aryl-4 thiazole pour le traitement de l'ulcère peptique
ES2054684T3 (es) * 1986-10-29 1994-08-16 Pfizer Procedimientos para la preparacion de 2-(1-pentil-3-guanidino)-4-(2-metil-4-imidazolil) tiazol y el dihidrocloruro trihidratado cristalino del mismo.
WO1994028898A1 (fr) * 1993-06-15 1994-12-22 Pfizer Inc. Antagonistes d'h2 utilises comme stimulants immunitaires pour traiter des infections bacteriennes chez le betail ou les cochons
US8536185B2 (en) 2008-09-22 2013-09-17 Cayman Chemical Company, Incorporated Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases
WO2022034121A1 (fr) 2020-08-11 2022-02-17 Université De Strasbourg Bloqueurs de h2 ciblant des macrophages du foie pour la prévention et le traitement d'une maladie du foie et du cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519637A (en) 1966-12-06 1970-07-07 Hoffmann La Roche 1-(4-thiazolylmethyl)nitroimidazole derivatives
DE2142585A1 (de) * 1971-08-20 1973-02-22 Schering Ag 2-(5-nitro-2-thiazolyl)-benzimidazole
FR2284601A1 (fr) * 1974-09-10 1976-04-09 Inst Francais Du Petrole Composes guanidino-heterocycliques alkyles, leur preparation et leur utilisation comme additifs pour carburants et lubrifiants
US4220654A (en) 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
US4374843A (en) 1980-10-14 1983-02-22 Pfizer Inc. 2-Guanidino-4-heteroarylthiazoles

Also Published As

Publication number Publication date
ATE33649T1 (de) 1988-05-15
KR860000931B1 (ko) 1986-07-19
PL141199B1 (en) 1987-07-31
CA1201120A (fr) 1986-02-25
AU539244B2 (en) 1984-09-20
YU99683A (en) 1986-02-28
PL241840A1 (en) 1985-01-16
YU42857B (en) 1988-12-31
JPS58206588A (ja) 1983-12-01
CS318483A2 (en) 1987-02-12
IE831061L (en) 1983-11-10
DE3376322D1 (en) 1988-05-26
IL68630A0 (en) 1983-09-30
HU190899B (en) 1986-12-28
AU3081584A (en) 1984-11-08
FI831595L (fi) 1983-11-11
NO159932C (no) 1989-02-22
IE55229B1 (en) 1990-07-04
NO159932B (no) 1988-11-14
AU566755B2 (en) 1987-10-29
DK163829B (da) 1992-04-06
EG17029A (en) 1992-06-30
ES522223A0 (es) 1984-08-16
EP0094191B1 (fr) 1988-04-20
KR840004745A (ko) 1984-10-24
NO831632L (no) 1983-11-11
PT76662A (en) 1983-06-01
AU1436383A (en) 1983-11-17
IL68630A (en) 1987-03-31
SU1195907A3 (ru) 1985-11-30
DK205883D0 (da) 1983-05-09
FI78481B (fi) 1989-04-28
DK205883A (da) 1983-11-11
GR79279B (fr) 1984-10-22
ZA833286B (en) 1984-12-24
HU196377B (en) 1988-11-28
FI78481C (fi) 1989-08-10
ES8407045A1 (es) 1984-08-16
FI831595A0 (fi) 1983-05-09
EP0094191A1 (fr) 1983-11-16
PT76662B (en) 1986-04-16
DD209828A5 (de) 1984-05-23
GT198302123A (es) 1984-10-27
NZ204158A (en) 1986-05-09
US4435396A (en) 1984-03-06

Similar Documents

Publication Publication Date Title
KR960007524B1 (ko) 치환된 이미다졸릴-알킬-피페라진 및 -디아제핀 유도체
US7071189B2 (en) Heterocyclic compound and antitumor agent containing the same as active ingredient
RU2136682C1 (ru) Имидазопиридины, способ их получения, фармацевтическая композиция на их основе и способ получения фармацевтической композиции
RU2434851C1 (ru) Циклические n, n'-диарилтиомочевины или n, n'-диарилмочевины - антагонисты андрогенных рецепторов, противораковое средство, способ получения и применения
CS248750B2 (en) Production method of the 2-(n-subst.guanidino)-4-heteroarylthiazols
CA2633958C (fr) Composes et procedes d'inhibition de l'interaction des proteines bcl avec des partenaires de liaison
EP0079545A1 (fr) Dérivés de benzimidazole, procédé pour leur préparation et compositions pharmaceutiques les contenant
CS252461B2 (en) Method of 2-guanidino-4-(2-subst.-amino-4-imidazolyl)thiazoles production
GB2243832A (en) 2-substituted 4-acetamido-5-chloro-n-[2-(diethylamino)ethyl]-benzamide derivative
CS231182B2 (en) Processing method of 2-guanidine-4-imidazolythissole
KR20020010482A (ko) 뉴로키닌 수용체 길항제로서의 신규한ｎ-트리아졸일메틸-피페라진 유도체
RU2138501C1 (ru) Имидазопиридиназолидиноны, их соли и лекарственное средство
DE2724501A1 (de) Neue, in 11-stellung substituierte 5,11-dihydro-6h-pyrido eckige klammer auf 2,3-b eckige klammer zu eckige klammer auf 1,4 eckige klammer zu benzodiazepin-6- one, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
KR900003368B1 (ko) 신규한 인데노티아졸 유도체의 제조방법
CZ290442B6 (cs) (R)-5-Brom-N-(1-ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridinkarboxamid, způsob jeho přípravy a farmaceutický prostředek, který jej obsahuje
EP0227026B1 (fr) Dérivés de la pyrazine, procédé pour leur préparation et compositions pharmaceutiques les contenant
Ram et al. Synthesis of potential antifilarial agents. 1. 1-(5-Benzoylbenzimidazol-2-yl)-3-alkyl and aryl ureas
WO2015091827A1 (fr) Dérivés de bendamustine et ses composés
KR840002172B1 (ko) 피리딜 아미노 트리아졸의 제조방법
EP0000151B1 (fr) Aminoindolines substituées en position 1, procédé de leur production et compositions thérapeutiques les contenant
EP0639568A1 (fr) Dérivés de pipéridine, leur préparation et leur utilisation dans le traitement des maladies neurodégénératives
CS241141B2 (en) Method of ethendiamine and guanidine derivatives production
EP0641784B1 (fr) Derive de benzimidazole, procede de production, antiemetique contenant ledit derive en tant qu'ingredient actif et agent de preparation dudit antiemetique
EP0199096B1 (fr) Composés hétéroaryles substitués par des groupes nitro, leur procédé de préparation et compositions pharmaceutiques les contenant
EP4201923A1 (fr) 2,3-dihydropyridine-4-ones 5-substitués et leur procédé de préparation